• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名患有胰岛素受体自身抗体和免疫复合物性肾小球肾炎的患者成功接受免疫抑制治疗。

Successful immunosuppressive therapy in a patient with autoantibodies to insulin receptors and immune complex glomerulonephritis.

作者信息

Sims R E, Rushford F E, Huston D P, Cunningham G R

出版信息

South Med J. 1987 Jul;80(7):903-6. doi: 10.1097/00007611-198707000-00023.

DOI:10.1097/00007611-198707000-00023
PMID:3603112
Abstract

Altered mental status, acanthosis nigricans, immune complex glomerulonephritis with nephrotic syndrome, fasting hypoglycemia, and postprandial hyperglycemia associated with anti-insulin receptor antibodies (type B insulin resistance) developed in a 43-year-old black woman who initially was treated for diabetes mellitus. Her HLA phenotype was A2, A29, Bw45(w6), B13(w4), Cw3, DR1 (DQw1). Her serum contained immune complexes, low complement levels, and antibodies that bound to the glomerular mesangium of mouse kidney. All clinical and serologic abnormalities resolved with combination cyclophosphamide and glucocorticoid treatment, and low doses of these agents have maintained the remission for more than a year.

摘要

一名43岁的黑人女性最初因糖尿病接受治疗,随后出现了精神状态改变、黑棘皮症、伴有肾病综合征的免疫复合物肾小球肾炎、空腹低血糖以及与抗胰岛素受体抗体相关的餐后高血糖(B型胰岛素抵抗)。她的HLA表型为A2、A29、Bw45(w6)、B13(w4)、Cw3、DR1 (DQw1)。她的血清中含有免疫复合物、低补体水平以及与小鼠肾脏肾小球系膜结合的抗体。联合使用环磷酰胺和糖皮质激素治疗后,所有临床和血清学异常均得到缓解,低剂量的这些药物已维持缓解状态超过一年。

相似文献

1
Successful immunosuppressive therapy in a patient with autoantibodies to insulin receptors and immune complex glomerulonephritis.一名患有胰岛素受体自身抗体和免疫复合物性肾小球肾炎的患者成功接受免疫抑制治疗。
South Med J. 1987 Jul;80(7):903-6. doi: 10.1097/00007611-198707000-00023.
2
Type B Insulin Resistance in Peru.秘鲁的B型胰岛素抵抗
Am J Med Sci. 2017 Mar;353(3):258-262. doi: 10.1016/j.amjms.2016.07.001. Epub 2016 Aug 30.
3
Regression of acanthosis nigricans correlates with disappearance of anti-insulin receptor autoantibodies and achievement of euglycemia in type B insulin resistance syndrome.黑棘皮病的消退与B型胰岛素抵抗综合征中抗胰岛素受体自身抗体的消失及血糖正常的实现相关。
Metabolism. 2007 May;56(5):670-5. doi: 10.1016/j.metabol.2006.12.016.
4
Antibody-Mediated Extreme Insulin Resistance: A Report of Three Cases.抗体介导的极端胰岛素抵抗:三例报告
Am J Med. 2018 Jan;131(1):102-106. doi: 10.1016/j.amjmed.2017.08.004. Epub 2017 Aug 16.
5
Induction of insulin resistance by autoantibodies to insulin receptors following on an acute Coxsackie B4 infection.急性柯萨奇B4病毒感染后,胰岛素受体自身抗体诱导胰岛素抵抗。
Diabetes Res Clin Pract. 1994 Oct;25(3):207-10. doi: 10.1016/0168-8227(94)90010-8.
6
Insulin receptor antibodies and insulin resistance.胰岛素受体抗体与胰岛素抵抗。
South Med J. 1999 Jul;92(7):717-9. doi: 10.1097/00007611-199907000-00013.
7
Systemic lupus erythematosus with acanthosis nigricans, hyperpigmentation, and insulin receptor antibody.伴有黑棘皮病、色素沉着及胰岛素受体抗体的系统性红斑狼疮
Lupus. 1997;6(3):275-8. doi: 10.1177/096120339700600311.
8
Treatment of type B insulin resistance: a novel approach to reduce insulin receptor autoantibodies.治疗 B 型胰岛素抵抗:一种降低胰岛素受体自身抗体的新方法。
J Clin Endocrinol Metab. 2010 Aug;95(8):3641-7. doi: 10.1210/jc.2010-0167. Epub 2010 May 19.
9
Remission of insulin resistant diabetes in two patients with anti-insulin receptor antibodies.
Tohoku J Exp Med. 1982 Oct;138(2):187-97. doi: 10.1620/tjem.138.187.
10
Combined Immunosuppressive Therapy Induces Remission in Patients With Severe Type B Insulin Resistance: A Prospective Cohort Study.联合免疫抑制疗法可诱导严重 B 型胰岛素抵抗患者缓解:一项前瞻性队列研究。
Diabetes Care. 2018 Nov;41(11):2353-2360. doi: 10.2337/dc18-0884. Epub 2018 Sep 10.

引用本文的文献

1
Type B insulin resistance syndrome: a systematic review.B型胰岛素抵抗综合征:一项系统评价
Arch Endocrinol Metab. 2020 Aug;64(4):337-348. doi: 10.20945/2359-3997000000257. Epub 2020 Jun 5.
2
Saibokuto as a Possible Therapy for Type B Insulin Resistance Syndrome: The Disappearance of Anti-insulin Receptor Antibody and a Marked Amelioration of Glycemic Control by Saibokuto Treatment.柴朴汤作为B型胰岛素抵抗综合征的一种可能疗法:柴朴汤治疗后抗胰岛素受体抗体消失及血糖控制显著改善
Intern Med. 2018 Aug 15;57(16):2359-2363. doi: 10.2169/internalmedicine.0523-17. Epub 2018 Mar 9.
3
Treatment of type B insulin resistance: a novel approach to reduce insulin receptor autoantibodies.
治疗 B 型胰岛素抵抗:一种降低胰岛素受体自身抗体的新方法。
J Clin Endocrinol Metab. 2010 Aug;95(8):3641-7. doi: 10.1210/jc.2010-0167. Epub 2010 May 19.
4
Insulin receptor substrate 1 binds two novel splice variants of the regulatory subunit of phosphatidylinositol 3-kinase in muscle and brain.胰岛素受体底物1在肌肉和大脑中与磷脂酰肌醇3激酶调节亚基的两种新型剪接变体结合。
Mol Cell Biol. 1996 May;16(5):2195-203. doi: 10.1128/MCB.16.5.2195.